Recruitment via a CCL1 Dependent Pathway Statins Induce Regulatory T Cell

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells.

  2008cited by this paper
• Statins inhibit lymphocyte homing to peripheral lymph nodes

  2007cited by this paper
• CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells

  2007cited by this paper
• Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease

  2007cited by this paper
• Statins and the vascular endothelial inflammatory response.

  2007cited by this paper
• Coordinated Involvement of Mast Cells and T Cells in Allergic Mucosal Inflammation: Critical Role of the CC Chemokine Ligand 1:CCR8 Axis

  2007cited by this paper
• Distinctive role of CCR7 in migration and functional activity of naive‐ and effector/memory‐like Treg subsets

  2007cited by this paper
• Dendritic Cell Interactions with Bacteria: Subpopulations and differentiation of mouse dendritic cells

  2007cited by this paper
• Candida albicans Triggers Activation of Distinct Signaling Pathways to Establish a Proinflammatory Gene Expression Program in Primary Human Endothelial Cells1

  2007cited by this paper
• Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

  2006cited by this paper
• Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis.

  2006cited by this paper
• Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin

  2006cited by this paper
• The Role of Rho-Associated Kinase in Differential Regulation by Statins of Interleukin-1β- and Lipopolysaccharide-Mediated Nuclear Factor κB Activation and Inducible Nitric-Oxide Synthase Gene Expression in Vascular Smooth Muscle Cells

  2006cited by this paper
• Atorvastatin Restores Lck Expression and Lipid Raft-Associated Signaling in T Cells from Patients with Systemic Lupus Erythematosus1

  2006cited by this paper
• CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes

  2006influential reference
• Differential effects of statins on relevant functions of human monocyte‐derived dendritic cells

  2006cited by this paper
• Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells

  2006cited by this paper
• CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to cites of atopic skin inflammation

  2005cited by this paper
• Statins and cancer prevention

  2005cited by this paper
• CCL1-CCR8 Interactions: An Axis Mediating the Recruitment of T Cells and Langerhans-Type Dendritic Cells to Sites of Atopic Skin Inflammation1

  2005cited by this paper
• Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction1

  2005cited by this paper
• Impact of Statin Treatment on 1-Year Functional and Histologic Renal Allograft Outcome

  2005cited by this paper
• Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.

  2005cited by this paper
• Statins for atherosclerosis--as good as it gets?

  2005cited by this paper
• Mechanisms of Statin-mediated Inhibition of Small G-protein Function*

  2005cited by this paper
• Effect of Simvastatin, an Established Lipid-Lowering Drug, on Pulmonary Chlamydia pneumoniae Infection in Mice

  2005cited by this paper
• Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing.

  2004cited by this paper
• Developmental Stage, Phenotype, and Migration Distinguish Naive- and Effector/Memory-like CD4+ Regulatory T Cells

  2004cited by this paper
• Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

  2004cited by this paper
• Statins Inhibit HIV-1 Infection by Down-regulating Rho Activity

  2004cited by this paper
• Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface

  2004cited by this paper
• Statin Compounds Reduce Human Immunodeficiency Virus Type 1 Replication by Preventing the Interaction between Virion-Associated Host Intercellular Adhesion Molecule 1 and Its Natural Cell Surface Ligand LFA-1

  2004cited by this paper
• Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice1

  2004cited by this paper
• A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells

  2004cited by this paper
• Chemokines: multiple levels of leukocyte migration control.

  2004cited by this paper
• Skin‐versus gut‐skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells

  2003cited by this paper
• Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

  2003cited by this paper
• Anti-inflammatory and immunomodulatory effects of statins.

  2003cited by this paper
• Expression of the T‐helper 2‐specific chemokine receptor CCR4 on CCR10‐positive lymphocytes in atopic dermatitis skin but not in psoriasis skin

  2003cited by this paper
• Treatment of Relapsing Paralysis in Experimental Encephalomyelitis by Targeting Th1 Cells through Atorvastatin

  2003cited by this paper
• Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 or Th2 cells

  2002cited by this paper
• The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

  2002cited by this paper
• Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes

  2002cited by this paper
• Chemokine Receptor Expression and Function in CD4+ T Lymphocytes with Regulatory Activity1

  2001cited by this paper
• B cells and professional APCs recruit regulatory T cells via CCL4

  2001cited by this paper
• Aberrant in Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in Cc Chemokine Receptor 8 Knockout Mice

  2001cited by this paper
• Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells

  2001cited by this paper
• Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

  2001cited by this paper
• Statins as a newly recognized type of immunomodulator

  2000cited by this paper
• Simvastatin Improves Disturbed Endothelial Barrier Function

  2000cited by this paper
• The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells.

  1998cited by this paper
• Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.

  1998cited by this paper
• The use of embryonic stem cells for the genetic manipulation of the mouse.

  1998cited by this paper
• Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice.

  1996cited by this paper

• No citing papers are available for this paper.